Dwivedi, Deepanjali https://orcid.org/0000-0001-9992-9167
Dumontier, Dimitri https://orcid.org/0000-0002-5515-2162
Sherer, Mia https://orcid.org/0000-0001-9303-1540
Lin, Sherry https://orcid.org/0000-0002-1275-8391
Mirow, Andrea M. C.
Qiu, Yanjie https://orcid.org/0000-0002-3820-0855
Xu, Qing
Liebman, Samuel A.
Joseph, Djeckby
Datta, Sandeep R.
Fishell, Gord https://orcid.org/0000-0002-9640-9278
Pouchelon, Gabrielle https://orcid.org/0000-0002-8025-059X
Funding for this research was provided by:
European Molecular Biology Organization (Long-term Fellowship)
Pershing Square Foundation (Pershing Square Innovation Fund)
Hearst foundation fellowship; National Swiss Foundation postdoc fellowships
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH071679, MH095147)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS08297, NS074972)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Simons Foundation (SFARI)
Article History
Received: 18 December 2023
Accepted: 24 May 2024
First Online: 26 June 2024
Competing interests
: Gord Fishell is a founder of Regel Therapeutics, which has no competing interests with the present manuscript. The remaining authors declare no competing interests.